Contemporary Oncology

Termedia Publishing House

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Contemporary Oncology is an open-access journal published by Termedia Publishing House in Poland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,650 PLN. Declared review time at DOAJ: 24 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Termedia Publishing House
ISSN
1428-2526 · 1897-4309
Country
Poland
Languages
english
Access
Open access
Declared publication charge
1,650 PLN
Articles in DOAJ
449
Declared review time
24 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2016-11-29
Indexing
DOAJ
APC
1,650 PLN
Declared review time (DOAJ)
24 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

449

Most recent article

last month

Average review time (journal-declared via DOAJ)

24weeks

Works in OpenAlex

1067

Last recorded publication year

2025

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

43

i10-index

287

From OpenAlex open data (CC0).

Editorial & policy10
Added to DOAJ
2016-11-29
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMC
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Contemporary Oncology
Source type
journal
NLM unique ID (PubMed)
101233223
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • Multiple and Secondary Primary Cancers
  • Multiple and Secondary Primary Cancers
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Head and Neck Cancer Studies
  • Head and Neck Cancer Studies
Show all subjects (50)
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Inflammatory Biomarkers in Disease Prognosis
  • Inflammatory Biomarkers in Disease Prognosis
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Renal cell carcinoma treatment
  • Renal cell carcinoma treatment
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Lung Cancer Research Studies
  • Genetic factors in colorectal cancer
  • Pancreatic and Hepatic Oncology Research
  • Genetic factors in colorectal cancer
  • Lung Cancer Research Studies
  • Pancreatic and Hepatic Oncology Research
  • Cancer Risks and Factors
  • Glioma Diagnosis and Treatment
  • Cancer Risks and Factors
  • Neuroendocrine Tumor Research Advances
  • Glioma Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Cancer Immunotherapy and Biomarkers
  • Gastric Cancer Management and Outcomes
  • Gastric Cancer Management and Outcomes
  • Lung Cancer Diagnosis and Treatment
  • Childhood Cancer Survivors' Quality of Life
  • Cancer Immunotherapy and Biomarkers
  • Childhood Cancer Survivors' Quality of Life
  • Sarcoma Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Sarcoma Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • PI3K/AKT/mTOR signaling in cancer
  • Advanced Radiotherapy Techniques
  • PI3K/AKT/mTOR signaling in cancer
  • Advanced Radiotherapy Techniques

Keywords (DOAJ)

  • oncology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: